Skip to main content
. 2019 Jan 9;20(5):692–699. doi: 10.1080/15384047.2018.1550571

Table 1.

Subject characteristics.

Variable Controls CRC
Number of subjects 67 48
Age, median (range), years 48 (19–65) 71 (32–90)
Gender, n (% female) 18 (27%) 24 (50%)
BMI, median (range), kg/m2 26.2 (21.7–31.7) 26.6 (17.6–37.9)
Tumor location, n (%) Colon - 41 (85%)
  Rectum - 7 (15%)
Tumor stage, n (%) Stage 1 - 7 (15%)
  Stage 2 - 25 (52%)
  Stage 3 - 9 (19%)
  Stage 4 - 4 (8%)
  N/A - 3 (6%)
TNM classes, n (%) T1N0M0 - 1 (2%)
  T2N0M0 - 6 (13%)
  T2N1M0 - 1 (2%)
  T3N0M0 - 23 (49%)
  T3N1M0 - 1 (2%)
  T3N0M1 - 2 (4%)
  T3N1M0 - 2 (4%)
  T3N1M1 - 1 (2%)
  T3N2M0 - 3 (6%)
  T3N2M1 - 1 (2%)
  T4N0M0 - 2 (4%)
  T4N1M0 - 2 (4%)
  N/A - 3 (6%)
VI, n (%) No - 17 (36%)
  Yes - 27 (56%)
  N/A - 4 (8%)

CRC: colorectal cancer; BMI: body mass index; TNM: T: tumor, N: node, M: metastasis; VI: venous invasion